Technical Analysis for ETON - Eton Pharmaceutcials, Inc.

Grade Last Price % Change Price Change
grade C 5.94 -1.98% -0.12
ETON closed down 1.14 percent on Friday, October 18, 2019, on 1.55 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average.

Earnings due: Nov 8

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ETON trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish -1.98%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.98%
NR7 Range Contraction -1.98%
MACD Bearish Centerline Cross Bearish -3.10%
50 DMA Support Bullish -3.10%
Pocket Pivot Bullish Swing Setup -3.10%
Inside Day Range Contraction -3.10%
Fell Below 20 DMA Bearish -2.94%
50 DMA Support Bullish -2.94%
Spinning Top Other -2.94%

Older signals for ETON ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical product using the U.S. Food and Drug Administration's 505(b)(2) regulatory pathway. It primarily focuses on liquid products, including injectable, oral liquid, and ophthalmic products. The company is developing DS-300, an injectable nutrition product candidate; EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-103, an oral liquid product candidate; DS-100, an injectable product candidate for use in pain management; DS-200, an injectable parenteral nutrition product candidate; ET-101, an oral liquid product for use in seizure control; ET-102, an oral liquid product for use as a muscle relaxant; and CT-100, a synthetic corticotropin therapeutic candidate that mimics the amino acid chain of H.P. Acthar Gel. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Medicine Health Pharmaceutical Pain Pharmaceutical Industry In China Pharmaceuticals Policy Pain Management Science And Technology In The People's Republic Of China Ophthalmic Products Allergic Conjunctivitis Liquid Products Pharmaceutical Product
Is ETON a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.2
52 Week Low 5.13
Average Volume 87,529
200-Day Moving Average 6.9721
50-Day Moving Average 6.0081
20-Day Moving Average 6.2017
10-Day Moving Average 6.1224
Average True Range 0.4043
ADX 14.07
+DI 22.0255
-DI 23.061
Chandelier Exit (Long, 3 ATRs ) 6.2765
Chandelier Exit (Short, 3 ATRs ) 6.8629
Upper Bollinger Band 6.7265
Lower Bollinger Band 5.6769
Percent B (%b) 0.36
BandWidth 16.924392
MACD Line -0.0114
MACD Signal Line 0.0027
MACD Histogram -0.0141
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.39
Resistance 3 (R3) 6.39 6.27 6.34
Resistance 2 (R2) 6.27 6.19 6.28 6.32
Resistance 1 (R1) 6.17 6.14 6.11 6.17 6.30
Pivot Point 6.05 6.05 6.03 6.06 6.05
Support 1 (S1) 5.95 5.97 5.89 5.95 5.82
Support 2 (S2) 5.83 5.92 5.84 5.80
Support 3 (S3) 5.73 5.83 5.79
Support 4 (S4) 5.73